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Test accuracy studies assume the existence of a well-defined illness definition and
clear-cut diagnostic gold standards or reference standards. However, in clinical
reality illness definitions may be vague or a mere description of a set of
manifestations, mostly clinical signs and symptoms. This can lead to
disagreements among experts about the correct classification of an illness and the
adequate reference standard. Using data from a diagnostic accuracy study in
carpal tunnel syndrome, we explored the impact of different definitions on the
estimated test accuracy and found that estimated test performance characteristics
varied considerably depending on the chosen reference standard. In situations
without a clear-cut illness definition, randomized controlled trials may be
preferable to test accuracy studies for the evaluation of a novel test. These studies
do not determine the diagnostic accuracy, but the clinical impact of a novel test
on patient management and outcome.
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However, in clinical reality the biological understanding of
conditions is frequently unclear. Illness definitions are vague
or a mere description of a set of manifestations. In fields such
as psychiatry and rheumatology, clinicians frequently use
‘syndromal diagnoses’ consisting of a characteristic pattern of
signs and symptoms,3 while the biological understanding of the
condition, of its causes, and its manifestations is incomplete and
there is controversy about the manifestations that have to be
combined to ensure accurate representation of the condition. In
other situations, the biological understanding of the condition
may be comprehensive, but the measurement of signs or
symptoms is inaccurate.
Two extreme conceptualizations of the reference standard
may implicitly or explicitly be used in such circumstances. One
extreme ignores potential controversies and assumes a well-
defined illness, which is objectively and reproducibly repre-
sented by the outcome of one or several laboratory tests. The
other extreme ignores potentially useful biological measures and
focuses exclusively on patient outcomes or on the need for an
intervention. While these two outlooks aim at describing
the same issue, they may create a schism when evaluating a
diagnostic test. Below, we will explore this in a clinical example
of an accuracy study previously published by our group in the
field of rheumatology4 and discuss the potential implications
for clinical research into conditions without a clear-cut reference
standard by which to establish a diagnosis.
The notion of a diagnostic gold standard or reference standard
pertains to the best available method for establishing the presence
or absence of a condition of interest,1 i.e. the independent and
correct classification of what is meant to be the illness.2 The
traditional concept of a reference standard depends on a high
level of biological understanding of the target condition and its
causal underlying mechanisms. Typically, a morphological
verification such as histopathology or angiography, is used to
establish a ‘definite diagnosis’. This definite diagnosis is assumed
to be a reasonably reliable proxy measure of the true presence or
absence of the condition of interest.
In conventional diagnostic accuracy studies, the usefulness of
a novel test for the inclusion or exclusion of a specific condition
will be determined by comparing the results of the test with the
definite diagnosis ascertained by the reference standard.
Clinical example
Carpal Tunnel Syndrome (CTS) is an important cause of
functional impairment and pain of the hand, which presumably
results from a compression of the median nerve at the wrist.
Unfortunately, there is no universally accepted reference
standard to establish the diagnosis. In our experience, two
different approaches towards CTS classification are used.
Neurologists traditionally establish the definite diagnosis based
more on the outcome of nerve conduction studies than on
the patients’ signs and symptoms. In contrast, hand surgeons
appear to give considerably more importance to the patients’
signs and symptoms, the severity of complaints and the likely
need for and success of a surgical intervention than to nerve
conduction studies when establishing the definite diagnosis. In
our accuracy study,4 we relied on current practice and pre-
specified the neurologists’ definite diagnosis as the reference
standard. Here, we determine the impact of using either of the
two ‘reference standards’ on the estimated test accuracy of
sonography in patients with suspected CTS.
Methods and results
Details of methods are reported elsewhere.4 We assessed 77
patients for eligibility, excluded 3 because of traumatic wrist
lesions, and enrolled 74 referred to the outpatient clinic of the
Department of Hand Surgery at the University Hospital Berne,
Switzerland, between January and December 2002.
Patients included in the study had a mean age of 51 years
and 48 were females (65%). The flow of patients through the
various stages of the study is described elsewhere.4 Essentially,
101 wrists from 71 patients were included in the analysis.
Standardized nerve conduction studies were performed by
one of several neurologists, who were unaware of the results
of the sonographic examination. The sonographic evaluations
were performed by a rheumatologist experienced in muscu-
loskeletal sonography, who was unaware of the results of the
nerve conduction studies and of the patients’ signs and
symptoms. He performed transverse imaging of the median
nerve for the area ranging from the distal forearm to the outlet
of the carpal tunnel and measured the largest cross-sectional
area of the median nerve in square millimetres. We used this
measure as a single diagnostic indicator, assuming that an
increase in cross-sectional areas is associated with an increasing
likelihood of disease or disease severity.
Table 1 presents a comparison of definite diagnoses accord-
ing to neurologists’ and hand surgeons’ judgements. Overall
agreement was 86%. One out of 23 wrists classified as normal
by the neurologists was considered as CTS by the hand surgeons
(4%). This wrist had normal nerve conduction studies.
Conversely, 13 out of 78 wrists classified as CTS by the
neurologists were considered normal by the hand surgeons
(17%); all 13 wrists had pathological nerve conduction studies.
The resulting kappa for the agreement between the two illness
definitions was 0.67 [95% confidence interval (CI) 0.48–0.85].
For both reference standards, we fitted a receiver operating
characteristic (ROC) curve for diagnosis of CTS by sonography,
using a maximum likelihood logistic regression model based on
robust standard errors, which allowed for the correlation of
characteristics of wrists within patients and compared the area
under the ROC curve. Figure 1 shows the fitted ROC curves
using either the neurologists’ judgements (top) or the hand
surgeons’ judgements (bottom) as the reference standard. The
area under the ROC curve for ultrasound was 0.89 based on
neurologists’ judgements (95% CI 0.82–0.96) and 0.77 based on
hand surgeons’ judgements (95% CI 0.68–0.87). The difference
between the two areas under the ROC curve was 0.12 (95%
CI 0.0–0.23).
954 INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
0
0.5
0.25
0.75
1
Tr
ue
 p
os
itiv
e 
ra
te
 (s
en
sit
ivi
ty)
0
0.25
0.5
0.75
1
0 0.25 0.5 0.75 1
False positive rate (1 – specificity)
Tr
ue
 p
os
itiv
e 
ra
te
 (s
en
sit
ivi
ty)
Figure 1 Fitted ROC curves (solid curve) for diagnosis of CTS by
sonography with 95% confidence interval (dotted curves), considering
the neurologists’ definite diagnosis (top) or the hand surgeons’ definite
diagnosis as the reference standard (bottom). The broken diagonal line
represents a hypothetical ROC curve of a test that yields no diagnostic
information
Table 1 2  2 contingency table comparing reference standard
classifications according to neurologists and hand surgeons
Hand surgeons’ judgements
CTS present CTS absent Total
Neurologists’ judgements
CTS present 65 13 78
CTS absent 1 22 23
Total 66 35 101
Discussion
Even though the agreement between the two employed illness
definitions was substantial (a kappa of 0.67), the estimated test
performance of ultrasound varied considerably depending on
the definition used as the reference standard. The diagnostic
accuracy of sonography in patients with suspected CTS was
good to excellent according to one reference standard but only
moderate according to the other.
The lack of consensus on an illness definition may impede
a valid evaluation of diagnostic technology in test accuracy
studies. Considering that the final purpose of any novel test is
to improve patient management and outcome, the traditional
paradigm of test accuracy studies will only be useful if a
reference standard is chosen that either has a strong associa-
tion with patient outcome or a direct relationship with patient
management. In our accuracy study4 we argued, for example,
that the neurologists’ definite diagnosis directly pertains to
clinical decision making and patient management.
Ultimately, the use of a diagnostic test and its potential
therapeutic consequences can be considered as two consecu-
tive steps of the same management strategy. Analogous to
traditional research into therapeutic interventions, randomized
trials may be designed to compare different strategies. In such
trials, patients will be randomly allocated to a management
strategy that includes the use of a novel test under evaluation, or
to a strategy that uses standard tests only. Ascertained outcomes
may relate to parameters of patient management (e.g. length of
hospital stay), to patient outcome (e.g. pain), or to the total cost of
management per patient.5 If an unanimously accepted reference
standard is lacking, as is the case in CTS, such randomized
controlled trials may be more appropriate than test accuracy
studies to determine the usefulness of a novel diagnostic test.
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